BACKGROUND: Individuals with Down's syndrome (DS) are at high risk of developing Alzheimer's disease (AD). However, few studies have investigated brain anatomy in DS individuals with AD. METHOD: We compared whole brain anatomy, as measured by volumetric magnetic resonance imaging (MRI), in DS individuals with and without AD. We also investigated whether volumetric differences could reliably classify DS individuals according to AD status. We used volumetric MRI and manual tracing to examine regional brain anatomy in 19 DS adults with AD and 39 DS adults without AD. RESULTS: DS individuals with AD had significantly smaller corrected volumes bilaterally of the hippocampus and caudate, and right amygdala and putamen, and a significantly larger corrected volume of left peripheral cerebrospinal fluid (CSF), compared to DS individuals without AD. The volume of the hippocampus and caudate nucleus correctly categorized 92% and 92% respectively of DS individuals without AD, and 75% and 80% respectively of DS individuals with AD. CONCLUSIONS: DS individuals with AD have significant medial temporal and striatal volume reductions, and these may provide markers of clinical AD.
BACKGROUND: Individuals with Down's syndrome (DS) are at high risk of developing Alzheimer's disease (AD). However, few studies have investigated brain anatomy in DS individuals with AD. METHOD: We compared whole brain anatomy, as measured by volumetric magnetic resonance imaging (MRI), in DS individuals with and without AD. We also investigated whether volumetric differences could reliably classify DS individuals according to AD status. We used volumetric MRI and manual tracing to examine regional brain anatomy in 19 DS adults with AD and 39 DS adults without AD. RESULTS: DS individuals with AD had significantly smaller corrected volumes bilaterally of the hippocampus and caudate, and right amygdala and putamen, and a significantly larger corrected volume of left peripheral cerebrospinal fluid (CSF), compared to DS individuals without AD. The volume of the hippocampus and caudate nucleus correctly categorized 92% and 92% respectively of DS individuals without AD, and 75% and 80% respectively of DS individuals with AD. CONCLUSIONS: DS individuals with AD have significant medial temporal and striatal volume reductions, and these may provide markers of clinical AD.
Authors: S K Madsen; A J Ho; X Hua; P S Saharan; A W Toga; C R Jack; M W Weiner; P M Thompson Journal: Neurobiol Aging Date: 2010-06-11 Impact factor: 4.673
Authors: Andrea Romano; Marta Moraschi; Riccardo Cornia; Alessandro Bozzao; Olga Gagliardo; Laura Chiacchiararelli; Cristina Iani; Giacomo Stella; Giorgio Albertini; Alberto Pierallini Journal: Neuroradiology Date: 2015-01-06 Impact factor: 2.804
Authors: Marwan N Sabbagh; Adam Fleisher; Kewei Chen; Joseph Rogers; Camryn Berk; Eric Reiman; Michael Pontecorvo; Mark Mintun; Daniel Skovronsky; Sandra A Jacobson; Lucia I Sue; Carolyn Liebsack; Albert S Charney; Lauren Cole; Christine Belden; Thomas G Beach Journal: Arch Neurol Date: 2011-11
Authors: David Powell; Allison Caban-Holt; Gregory Jicha; William Robertson; Roberta Davis; Brian T Gold; Frederick A Schmitt; Elizabeth Head Journal: Neurobiol Aging Date: 2014-02-04 Impact factor: 4.673
Authors: Ann D Cohen; Eric McDade; Brad Christian; Julie Price; Chester Mathis; William Klunk; Benjamin L Handen Journal: Alzheimers Dement Date: 2018-03-01 Impact factor: 21.566
Authors: Katherine A Koenig; Se-Hong Oh; Melissa R Stasko; Elizabeth C Roth; H Gerry Taylor; Stephen Ruedrich; Z Irene Wang; James B Leverenz; Alberto C S Costa Journal: Brain Commun Date: 2021-04-19
Authors: Katherine A Koenig; Lynn M Bekris; Stephen Ruedrich; Grace E Weber; Maria Khrestian; Se-Hong Oh; Sanghoon Kim; Z Irene Wang; James B Leverenz Journal: Brain Imaging Behav Date: 2020-10-18 Impact factor: 3.224